Bristol Myers Squibb (BMY) Construction in Progress (2015 - 2026)

Bristol Myers Squibb (BMY) has 12 years of Construction in Progress data on file, last reported at $1.5 billion in Q1 2026.

• Construction in Progress for Q1 2026 came in at $1.5 billion, down 6.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (down 6.94% YoY), and the FY2025 annual result was $1.6 billion, up 6.16% from the prior year.
• Construction in Progress fell to $1.5 billion in Q1 2026 per BMY's latest filing, from $1.6 billion in the prior quarter.
• Over five years, Construction in Progress peaked at $1.8 billion in Q2 2025 and troughed at $800.0 million in Q1 2022.
• A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Construction in Progress.
• The sharpest annual moves came in 2022 and 2026: Construction in Progress soared 54.14% in 2022, then declined 6.94% in 2026.
• A 5-year view of Construction in Progress shows it stood at $1.1 billion in 2022, then grew by 2.09% to $1.1 billion in 2023, then jumped by 41.86% to $1.5 billion in 2024, then grew by 6.16% to $1.6 billion in 2025, then fell by 4.82% to $1.5 billion in 2026.
• Business Quant data shows BMY's Construction in Progress at $1.5 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.5 billion in Q3 2025.